Hotung Investment (和通）

[cyclone]

Listing of An Investee Company - Foresee Pharmaceuticals Co., Ltd.

Hotung Investment Holdings Limited announced the listing of one of its investee companies, Foresee Pharmaceuticals Co., Ltd., on the Taipei Exchange on 29 June 2018.

The Group had invested in Foresee since February 2016.

Information on Foresee
Foresee is a clinical-stage pharmaceutical company. The core competency of Foresee includes rapid development and commercialization of new drugs using its proprietary drug delivery technology, the Stabilized Injectable Formulation platform (SIF), as well as developing first-in-class New Chemical Entity (NCE) in disease areas of high unmet medical needs.

Based on its core competency, Foresee has developed two global patent protected new drugs, FP-001 and FP-025, currently in clinical development stage. The FP-001 50mg phase 3 registration study in advanced prostate cancer has successfully hit the primary endpoints and another formulation of 25mg is currently on the phase 3 registration trial. The FP-025, a small molecule MMP-12 inhibitor for the treatment of asthma / chronic obstructive pulmonary disease, just launched its phase 2 study in Netherlands.

In 2017, Foresee and Switzerland based pharmaceutical company, Ferring Pharmaceuticals, have entered into an exclusive worldwide development and option agreement to leverage Foresee’s proprietary and unique Stabilized Injectable Formulation platform (SIF) for the development of long duration, controlled release formulations of a peptide therapeutic. Under the terms of the agreement, Ferring will fund the development work and, upon completion, Ferring will have the right to exercise its option and enter into a definitive agreement with Foresee.

[noobinvestors]

A brief write up for Hotung Investment

https://writingofinvestingnoob.com/2019/...eld-stock/

Indeed huge cash balance (40% of market cap), but there is no recurrent cashflow to support the dividend, so each year dividend will be continuously drawing out from cash reserve. 

[cyclone]

Listing of An Investee Company -  Jiangsu Cnano Technology Co., Ltd.

Hotung Investment Holdings Limited announced the listing of one of its investee companies, Jiangsu Cnano Technology Co., Ltd. ("Cnano"), on the Shanghai Stock Exchange STAR market on 25 September 2019.

The Group had invested in Cnano since March 2015.

Information on Cnano
Cnano was founded in 2011 and has begun mass production since 2012. Now its headquarters is located at Zhenjiang city of Jiangsu Province in PRC.

Cnano is a leader in the manufacturing, R&D and commercialization of high quality multi-wall carbon nanotubes (“CNTs”) and graphene products for the energy storage, structural and electronics industries, especially lithium-ion battery, conductive plastic and anti-static paint. Cnano continues to leverage and enhance upon technologies it has licensed on an exclusive basis from Tsinghua University. Leveraging with the technologies, Cnano has developed the technology for mass production of multi-wall carbon nanotubes (MWCNT) and its applications.

CNTs have a large specific surface area and excellent electrical conductivity due to their unique hollow structure and nanometer size. When CNTs are used in the electrode material of activated carbon in the capacitor, they will help improving the charge storage, increasing the capacity and reducing the internal resistance of the capacitor. Because of their good electrical conductivity, CNTs will provide the larger power output under the high-power current demand.

[BlueKelah]

Listing of An Investee Company -  Jiangsu Cnano Technology Co., Ltd.

Hotung Investment Holdings Limited announced the listing of one of its investee companies, Jiangsu Cnano Technology Co., Ltd. ("Cnano"), on the Shanghai Stock Exchange STAR market on 25 September 2019.

The Group had invested in Cnano since March 2015.

Information on Cnano
Cnano was founded in 2011 and has begun mass production since 2012. Now its headquarters is located at Zhenjiang city of Jiangsu Province in PRC.

Cnano is a leader in the manufacturing, R&D and commercialization of high quality multi-wall carbon nanotubes (“CNTs”) and graphene products for the energy storage, structural and electronics industries, especially lithium-ion battery, conductive plastic and anti-static paint. Cnano continues to leverage and enhance upon technologies it has licensed on an exclusive basis from Tsinghua University. Leveraging with the technologies, Cnano has developed the technology for mass production of multi-wall carbon nanotubes (MWCNT) and its applications.

CNTs have a large specific surface area and excellent electrical conductivity due to their unique hollow structure and nanometer size. When CNTs are used in the electrode material of activated carbon in the capacitor, they will help improving the charge storage, increasing the capacity and reducing the internal resistance of the capacitor. Because of their good electrical conductivity, CNTs will provide the larger power output under the high-power current demand.

Good news, hopefully hotung can divest some at IPO and lock in some profit. Hotung price has slowly trended down to 1.50+ for a while now from $2 highs. Looks like  a good entry point to start collect again.

[fallscushion]

Another decent result from Hotung:
https://links.sgx.com/FileOpen/2020%20Fu...eID=649352

Dividend Per Share：NT$4.02484 per share (or about S$0.19).
A low profile and under-followed VC flowing nicely with the Tech tide (in China & Taiwan).

"The Group’s portfolio of investments remain in resilient sectors. We continue to focus on
these sectors, including 5G and cloud computing. "

[¯|_(ツ)_/¯]

@behappyalways - I just spend the last 10 mins looking at Hotung and it's definitely a good company. Thanks for your recommendation.



Gratitude.

[LionFlyer]

Re Hotung, good company but question is whether exposure to TW is a good thing with geopolitical tension in the next few years getting worst, not better.

[BlueKelah]

Re Hotung, good company but question is whether exposure to TW is a good thing with geopolitical tension in the next few years getting worst, not better.

Its actually exposure to greater China as they are VC for Taiwan and China based startups and will get their listing/IPO done on both markets. 

China along with other BRICS economy are probably going to be the next generation powerhouse countries, possibly China may eventually take over reserve currency / global monetary system. So longer term will be excellent for Hotung.

In the short term though, its gonna be hard days for E.M. economies /stock markets with rising rates hitting them hard. So very likely Hotung will be affected by this rather than geopolitics which currently is still in the Ukraine/European region.

[weijian]

As far back as FY17, China/Taiwan accounted for ~95% of all Hotung's existing investments.

In AR21, China/Taiwan's share reduced considerably to ~76%, with an "Others" category taking up ~18.2% of existing investments. This "Others" category was revealed to be mainly attributed to Israel based on AR22. In fact from AR22, Israel now accounts for ~23% of existing investments, with China/Taiwan further reducing to 70%.

Is this going out of their circle of competence? Or is this healthy diversification to Startup Nation, that may eventually bear fruits several years down the road?


Lessons from Tel Aviv: What Has Fueled Israel’s Startup Ecosystem’s Growth

Why is the Israeli startup ecosystem a beacon of success on the global tech scene

https://therecursive.com/lessons-from-te...-s-growth/